Answers are grounded in this paper and cite their sources.
Background Ovarian cancer is the eighth leading cause of cancer death in women. We treat the tissue layer as the five-group power module of ovulation, pickup and ciliary transport, peritoneal clearance, lymphatic drainage, and reserve and steroidogenesis, and ask whether a seven-state linear model reproduces SEER incidence, places the module at O3 and the products at O4, and whether screening samples the wrong layer. Methods We built a seven-state model (H, O1-O7, D). Targets were assigned to the five groups by measured function, and PubMed records measured evidence volume and coverage. The model was calibrated to SEER 2012–2016 age-specific incidence, and AIC, BIC and leave-one-age-group cross-validation compared the one-state, three-state and seven-state structures. UKCTOCS and PLCO were used to test the screening layer. Results The seven-state model placed the module at O3, the products at O4 and the tubal precursor at O5. The five groups covered 54 targets and 1,946 records; the O4 groups covered 54 targets and 3,768. The one-state detection design had the lower AIC (17.67) because the four intermediate rates were nearly identical; the seven-state model retained O1-O7. UKCTOCS raised stage I/II detection by 39.2% without reducing mortality, and PLCO found a mortality rate ratio of 1.18. Conclusion The tissue layer of ovarian cancer is the five-group power module, and the tubal precursor is the earliest readout. Screening samples the ovarian lesion layer; the precursor sits in the tubal layer. O1-O4 is the tissue-layer chain, and O5-O7 is the established mutation-clone chain.
No takes yet. Share an insight, caveat, or question.
wei qiaoxuan (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: